Published in PLoS One on January 16, 2014
Revisiting caspases in sepsis. Cell Death Dis (2014) 0.91
Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum. PLoS One (2015) 0.83
Inhibition of Alveolar Macrophage Pyroptosis Reduces Lipopolysaccharide-induced Acute Lung Injury in Mice. Chin Med J (Engl) (2015) 0.82
Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice. Int Immunol (2016) 0.80
Cathelicidin impact on inflammatory cells. Cent Eur J Immunol (2015) 0.79
The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis. PLoS One (2015) 0.79
Neutrophil extracellular traps induce IL-1β production by macrophages in combination with lipopolysaccharide. Int J Mol Med (2017) 0.75
The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy. Pharmaceuticals (Basel) (2016) 0.75
A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP. PLoS One (2017) 0.75
INHIBITORY EFFECT OF EMODIN ON RAW 264.7 ACTIVATED WITH DOUBLE STRANDED RNA ANALOGUE POLY I:C. Afr J Tradit Complement Altern Med (2017) 0.75
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (1990) 17.86
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature (1992) 9.96
Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell (1995) 9.11
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ (2007) 7.74
Pyroptosis: host cell death and inflammation. Nat Rev Microbiol (2009) 7.63
Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc (2009) 6.71
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med (1993) 5.46
The P2X7 receptor: a key player in IL-1 processing and release. J Immunol (2006) 5.35
Mammalian defensins in the antimicrobial immune response. Nat Immunol (2005) 4.84
ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem (2006) 4.33
The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol (2000) 4.10
The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82
Caspase-1-induced pyroptotic cell death. Immunol Rev (2011) 3.47
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother (1998) 3.45
Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol (2002) 3.24
Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol (2012) 3.18
LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta (2006) 3.05
IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol (2010) 2.99
Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol (2010) 2.88
Molecular mechanisms of endotoxin tolerance. J Endotoxin Res (2004) 2.60
Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J Biol Chem (1993) 2.50
The search for effective therapy for sepsis: back to the drawing board? JAMA (2011) 2.46
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol (2004) 2.40
Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol (2005) 2.38
Molecular mechanisms involved in inflammasome activation. Trends Cell Biol (2009) 2.29
A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology (2002) 1.93
Sepsis. Am J Med (2007) 1.93
A calculated response: control of inflammation by the innate immune system. J Clin Invest (2008) 1.93
The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol (2009) 1.92
Extracellular ATP in the immune system: more than just a "danger signal". Sci Signal (2009) 1.78
Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am J Respir Crit Care Med (2006) 1.73
Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol (2001) 1.73
Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol (2003) 1.70
An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol (2006) 1.55
Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol (2001) 1.52
Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J Biol Chem (2001) 1.52
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother (2006) 1.45
Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol (2012) 1.44
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs (2011) 1.39
The human P2X7 receptor and its role in innate immunity. Tissue Antigens (2011) 1.32
ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem Int (1998) 1.24
Dysregulation of the immune response in severe sepsis. Am J Med Sci (2004) 1.17
NADPH oxidase NOX2 mediates rapid cellular oxidation following ATP stimulation of endotoxin-primed macrophages. J Immunol (2009) 1.14
Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol (2002) 1.10
The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J Biol Chem (2008) 1.08
Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection. Apoptosis (2009) 1.07
Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats. Pediatr Surg Int (2005) 1.04
Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. J Nippon Med Sch (2012) 1.01
P2X(7) receptor and macrophage function. Purinergic Signal (2009) 0.96
Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells. Int Immunol (2011) 0.88
Regulation by CRAMP of the responses of murine peritoneal macrophages to extracellular ATP. Biochim Biophys Acta (2009) 0.80
Modulation by LL-37 of the responses of salivary glands to purinergic agonists. Mol Pharmacol (2006) 0.80
Does blocking cytokines in sepsis work? Am J Respir Crit Care Med (2002) 0.80
Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice. Int Immunol (2009) 0.78
Potential diagnostic markers for disseminated intravascular coagulation of sepsis. Blood Rev (2015) 0.78
Physiological Levels of Pentraxin 3 and Albumin Attenuate Vascular Endothelial Cell Damage Induced by Histone H3 In Vitro. Microcirculation (2016) 0.76
New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open (2017) 0.75
Coagulopathy of Coronavirus Disease 2019. Crit Care Med (2020) 0.75